- Home
- MWA vs RLAY Comparison
MWA vs RLAY Comparison
Compare MWA & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MWA | RLAY |
|---|---|---|
| Founded | 1857 | 2015 |
| Country | United States | United States |
| Employees | 3500 | N/A |
| Industry | Metal Fabrications | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 4.1B |
| IPO Year | 2006 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MWA | RLAY |
|---|---|---|
| Price | $25.74 | $18.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | ★ $30.50 | $19.50 |
| AVG Volume (30 Days) | 1.3M | ★ 4.2M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.01% | N/A |
| EPS Growth | ★ 64.86 | 31.78 |
| EPS | ★ 0.65 | N/A |
| Revenue | ★ $1,429,700,000.00 | $15,355,000.00 |
| Revenue This Year | $4.78 | N/A |
| Revenue Next Year | $4.27 | $324.03 |
| P/E Ratio | $38.15 | ★ N/A |
| Revenue Growth | 8.75 | ★ 53.44 |
| 52 Week Low | $22.74 | $3.03 |
| 52 Week High | $31.00 | $20.79 |
Technical Indicators
Market Signals| Indicator | MWA | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 53.85 | 57.03 |
| Support Level | $25.41 | $12.10 |
| Resistance Level | $26.00 | $20.79 |
| Average True Range (ATR) | 0.60 | 1.29 |
| MACD | -0.00 | -0.13 |
| Stochastic Oscillator | 54.17 | 41.64 |
Price Performance
Historical ComparisonAbout MWA MUELLER WATER PRODUCTS
Mueller Water Products Inc is a U.S.-based company that manufactures and sells products and services used in the transmission, distribution, and measurement of water. The company operates in two segments: Water Flow Solutions and Water Management Solutions. The Water Flow Solutions segment, which derives maximum revenue for the company, includes products like iron gate valves, specialty valves, and service brass products. Water Management Solutions' portfolio includes fire hydrants, repair and installation, natural gas, metering, leak detection, and pressure management and control products and solutions. Geographically, the company derives a majority of its revenue from the United States and the rest from Canada and other international locations.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.